Dr. Jan Storek
Affiliations
Professor
Cumming School of Medicine, Department of Medicine
Professor
Cumming School of Medicine, Department of Oncology
Professor
Cumming School of Medicine, Department of Microbiology, Immunology and Infectious Diseases
Member
Arnie Charbonneau Cancer Institute
Full Member
The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases
Contact information
Web presence
Phone number
Office: 403.210.8630
Lab: 403.220.7671
For media enquiries, contact
Kelly Johnston
Senior Communications Specialist
Please submit your media request here
Preferred method of communication
Admin Assistant
Cindy Miskolczi-McCallum
Email: cindy.miskolczi.mccal@ucalgary.ca
Office: 403.210.3935
Background
Educational Background
Doctor of Medicine Medicine, Charles University, 1984
Doctor of Philosophy Medicine, Charles University, 1994
American Board of Internal Medicine Certification Internal Medicine, Hematology, Oncology, focus on Hematopoietic Cell Transplantation, University of California, Los Angeles, University of Washington, Seattle, Fred Hutchinson Cancer Research Center, Seattle, 1994
Biography
Dr. Storek is a Professor in the Departments of Medicine (Hematology), Oncology and Microbiology/Immunology/Infectious Diseases at the University of Calgary. He is also a member of the Arnie Charbonneau Cancer Institute and the Snyder Institute for Chronic Diseases. Dr. Storek’s major interest is in the immunology of allogeneic hematopoietic cell transplantation (HCT) and autologous HCT for systemic sclerosis.
Research
Areas of Research
- Hematopoietic cell transplantation (HCT)
- Prevention of graft-vs-host disease
- HCT for autoimmune diseases
Hematopoietic cell transplantation is used to treat hematologic malignancies, aplastic anemia and congenital defects of hematopoiesis. The most frequent complications are immune complications. These include either insufficient immunity against microorganisms or leukemic cells, leading to infections or leukemic relapse, or deleterious immunity leading to graft-versus-host disease (GVHD). We study how immunity develops after hematopoietic cell transplantation with the goal of preventing infections, relapse, and GVHD. Recent research interests have been the pharmacology of anti-thymocyte globulin, and transplantation for autoimmune diseases, primarily systemic sclerosis.
Participation in university strategic initiatives
Awards
- Fellow, American College of Physicians, 2010
- Executive Committee Member for the development of International Guidelines for Infection Prophylaxis after Hematopoietic Cell Transplantation, 2007-2009, 2007
- Alberta Heritage Foundation for Medical Research Clinical Investigator, 2006
- Canada Research Chair in Immunology, Tier 2, 2005
In the News
More Information
I am currently NOT accepting new MSc or PhD students.
Are you the profile owner?
Login to edit.